SCHEMBL2071787

SCHEMBL2071787

CC(C)[C@@H]1NC(=O)OC1=O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8923368 0.82
SCHEMBL25409598 0.79 KDM4E (0.41)
SCHEMBL25412146 0.79
SCHEMBL1220742 0.79 KDM4E (0.41)
SCHEMBL24569208 0.79 KDM4E (0.41)
SCHEMBL25409601 0.79 KDM4E (0.41)
SCHEMBL25412145 0.79
SCHEMBL25412141 0.79
SCHEMBL25408926 0.79 KDM4E (0.41)
SCHEMBL25410073 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122068110-A Amino acid type supermolecule gel polymer electrolyte and preparation method and application thereof 四川荣创新能动力系统有限公司 2026-05-19 CN claimed
CN-120022382-A Polyamino acid nanoparticle with lung targeting property, and preparation method and application thereof 苏州大学 2025-05-23 CN claimed
CN-118610579-A Application of nitrogen heterocyclic compound in lithium ion battery electrolyte, lithium ion battery electrolyte and lithium ion battery 仲恺农业工程学院 2024-09-06 CN claimed
CN-115475271-B Preparation method of amino acid/rare earth nanocrystalline/nanocellulose antibacterial hemostatic dressing 上海纳米技术及应用国家工程研究中心有限公司 2023-11-24 CN claimed
CN-115475271-A Preparation method of amino acid/rare earth nanocrystalline/nanocellulose antibacterial hemostatic dressing 上海纳米技术及应用国家工程研究中心有限公司 2022-12-16 CN claimed
EP-3584277-B1 ANTIMICROBIAL SILICONE RUBBER, PREPARATION METHOD THEREFOR AND USE THEREOF SUZHOU DOBIOM MEDICAL TECH CO LTD (CN) 2022-06-29 EP claimed
US-11001688-B2 Antimicrobial silicone rubber, preparation method therefor and use thereof Suzhou DOBION Medical Technology Co., Ltd. (CN) 2021-05-11 US claimed
CN-108329467-B Preparation method of hyperbranched antibacterial peptide polymer 中国科学院大学 2020-09-04 CN claimed
CN-122068110-A Amino acid type supermolecule gel polymer electrolyte and preparation method and application thereof 四川荣创新能动力系统有限公司 2026-05-19 CN disclosed
EP-4685150-A1 METHOD FOR PRODUCING AMIDE GROUP-CONTAINING COMPOUND USING N-CARBOXYAMINO ACID ANHYDRIDE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2026-01-28 EP disclosed
US-20250197360-A1 NOVEL DIAZEPINES THAT TARGET YELLOW FEVER VIRUS NON-STRUCTURAL 4B (NS4B) PROTEIN AND THEIR METHOD OF USE BARUCH S. BLUMBERG INSTITUTE 2025-06-19 US disclosed
CN-120022382-A Polyamino acid nanoparticle with lung targeting property, and preparation method and application thereof 苏州大学 2025-05-23 CN disclosed
US-12281205-B2 Modified antibacterial compositions and methods THE UNIVERSITY OF MELBOURNE (AU) 2025-04-22 US disclosed
CN-119072467-A Novel diazapine compounds targeting yellow fever virus non-structural 4B (NS 4B) protein and methods of use thereof 巴鲁克斯布伦博格研究所 2024-12-03 CN disclosed
US-20030008882-A1 Proteomimetic compounds and methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-01-09 US disclosed
US-20020173664-A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen MITSUI CHEMICALS, INC. (JP) 2002-11-21 US disclosed
WO-2002089738-A2 PROTEOMIMETIC COMPOUNDS AND METHODS YALE UNIVERSITY (US) 2002-11-14 WO disclosed
US-5104984-A Enantioselective process for producing 1-beta-methyl carbapenem antibiotic intermediates MERCK & CO., INC. (US) 1992-04-14 US disclosed
US-4791207-A THIA- OR OXAZOLIDINONES MERCK & CO., INC. (US) 1988-12-13 US disclosed
EP-0197432-A2 Enantioselective process for producing 1-beta-methylcarbapenem antibiotic intermediates MERCK & CO. INC. (US) 1986-10-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12281205-B2 Modified antibacterial compositions and methods TUFM, CLPTM1, MRPL21 ABCB1 1257/4885
US-20030008882-A1 Proteomimetic compounds and methods PACSIN2, HSP90B1, PHLPP2 ABCB1 1861/4885
US-20020173664-A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen DNPEP, HDGF, ANPEP ABCB1 4827/4885
US-20250197360-A1 NOVEL DIAZEPINES THAT TARGET YELLOW FEVER VIRUS NON-STRUCTURAL 4B (NS4B) PROTEIN AND THEIR METHOD OF USE CUL4B, BRD4, CUL4A ABCB1 417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.